ARTA
REGN icon

A.R.T. Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

A.R.T. Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-398
Closed -$222K – 12
2021
Q2 		$222K Buy
+398
New +$202K 9.63% 7
2021
Q1 		– Sell
-1,498
Closed -$724K – 98
2020
Q4 		$724K Buy
+1,498
New +$809K 3.35% 3
2019
Q4 		– Sell
-27,198
Closed -$7.54M – 1648
2019
Q3 		$7.54M Buy
27,198
+21,800
+404% +$6.45M 0.38% 37
2019
Q2 		$1.69M Buy
5,398
+600
+13% +$200K 0.1% 281
2019
Q1 		$1.97M Buy
+4,798
New +$1.98M 0.12% 240
2018
Q3 		– Sell
-11,595
Closed -$4M – 1647
2018
Q2 		$4M Sell
11,595
-13,200
-53% -$4.13M 0.16% 162
2018
Q1 		$8.54M Buy
24,795
+4,300
+21% +$1.5M 0.34% 37
2017
Q4 		$7.71M Buy
20,495
+17,300
+541% +$7.01M 0.34% 29
2017
Q3 		$1.43M Sell
3,195
-2,305
-42% -$1.1M 0.07% 392
2017
Q2 		$2.7M Buy
+5,500
New +$2.41M 0.14% 182
2016
Q3 		– Sell
-13,088
Closed -$4.57M – 1070
2016
Q2 		$4.57M Buy
13,088
+9,798
+298% +$3.77M 0.23% 97
2016
Q1 		$1.19M Buy
+3,290
New +$1.36M 0.05% 516
2015
Q4 		– Sell
-18,752
Closed -$8.72M – 1668
2015
Q3 		$8.72M Buy
18,752
+12,946
+223% +$6.95M 0.32% 59
2015
Q2 		$2.96M Buy
+5,806
New +$2.83M 0.1% 308
2014
Q4 		– Sell
-11,107
Closed -$4M – 1607
2014
Q3 		$4M Sell
11,107
-15,561
-58% -$5.22M 0.19% 140
2014
Q2 		$7.53M Buy
+26,668
New +$7.9M 0.39% 32
2013
Q3 		– Sell
-4,513
Closed -$1.01M – 1456
2013
Q2 		$1.01M Buy
+4,513
New +$1.05M 0.03% 622

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

A.R.T. Advisors's REGN Position: Q3 2021 in Review

A.R.T. Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q3 2021, closing a stake of 398 shares — an estimated $222K sold.

A.R.T. Advisors first reported a position in REGN in Q2 2013 and held it in 17 quarters. The position peaked at $8.72M in Q3 2015. 1,017 funds tracked by Wall St. Rank hold REGN as of Q3 2021.

  • A.R.T. Advisors reported no remaining Regeneron Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • A.R.T. Advisors sold 398 Regeneron Pharmaceuticals shares in Q3 2021, an estimated $222K.
  • A.R.T. Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • A.R.T. Advisors's Regeneron Pharmaceuticals position peaked at $8.72M in Q3 2015.
  • 1,017 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2021.

Based on A.R.T. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.